Waters Corp

Waters Corp(WAT)股票分析

$436.950

-7.079 (-1.62%)收盤時

Loading chart…
最高
448.390
開盤
444.480
成交量加權均價
439.11
成交量
901.96K
市值
16.99B
最低
431.990
成交金額
396.06M
企業價值/稅息折舊攤銷前利潤(TTM)
37.06

Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.

AI 分析 of Waters Corp (WAT)

持有

Currently, Waters Corp (WAT) is a hold. The stock is priced at $436.95, with a forward P/E of 24.75, indicating a reasonable valuation for growth potential. However, the recent negative trend in insider selling, which increased by 125.80%, raises concerns about confidence from company insiders. The RSI is at 53.60, suggesting the stock is neither overbought nor oversold, which aligns with a cautious approach at this time.

分析師評級(15)

-5.23% 下跌空間
持有
5 買進
9 持有
1 賣出
目前: 436.95
最低
350.00
平均
414.08
最高
480.00

BofA

2026-10-09

目標價

$465

中性

Barclays

2026-10-07

目標價

$500

增持

Guggenheim

2026-10-01

目標價

$490

買進

Goldman Sachs

2026-09-21

目標價

$515

買進

UBS

2026-09-09

目標價

$490

買進

估值指標

Waters Corp(WAT)目前預期本益比為 24.75,5 年平均預期本益比為 25.71。

預期本益比

合理
5 年均值 P/E
25.71
目前P/E
24.75
高估
29.03
低估
22.39

預期 EV/EBITDA

高估
5 年均值 EV/EBITDA
21.89
目前EV/EBITDA
37.06
高估
34.08
低估
9.69

預期股價營收比

合理
5 年均值 P/S
6.12
目前P/S
6.02
高估
7.10
低估
5.14

Alphio AI 對 WAT 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%WAT

$494.79

情境價格

基

基準

基準 · 50%WAT

$430.97

情境價格

悲

悲觀

悲觀 · 25%WAT

$340.64

情境價格

持有 WAT 的大戶

M

Mawer Investment Management Ltd.

+ 持有WAT

+10.13%

3個月報酬率

J

John W. Bristol & Co., Inc.

+ 持有WAT

+6.49%

3個月報酬率

A

Allspring Global Investments, LLC

+ 持有WAT

+5.64%

3個月報酬率

O

Osmosis Investment Management UK Limited

+ 持有WAT

+5.60%

3個月報酬率

V

Veritas Asset Management LLP

+ 持有WAT

+5.30%

3個月報酬率

A

ATB Investment Management Inc.

+ 持有WATMSFT

+5.10%

3個月報酬率

WAT 常見問題 —— 由 Alphio AI 解答

Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Currently, Waters Corp (WAT) is a hold. The stock is priced at $436.95, with a forward P/E of 24.75, indicating a reasonable valuation for growth potential. However, the recent negative trend in insider selling, which increased by 125.80%, raises concerns about confidence from company insiders. The RSI is at 53.60, suggesting the stock is neither overbought nor oversold, which aligns with a cautious approach at this time.

15 analysts cover WAT: 5 rate it Buy, 9 Hold and 1 Sell. The average price target is 414.08.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易